Male urethral stricture disease is highly prevalent and difficult to treat due to potential complications. Minimally invasive treatments tend to have high recurrence rates, keeping urethroplasty as the gold standard. Collagenase Clostridium histolyticum (CCH) has been used in humans to treat fibrosis in a minimally invasive manner. Herein, we present the preliminary results from treatments of three males with urethral stricture as a feasibility and safety evaluation of the first-in-human CCH treatment for male urethral stricture disease.
Cureus. 2023 Sep 11*** epublish ***
Lucas R Wiegand, Thanh Q Tran, Kevin Heinsimer, Bhavik Shah
Department of Urology, University of South Florida, Tampa, USA., Department of Urology, Advanced Urology, Decatur, USA.